Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 21318 | 424 | 45.9 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
| 29 | 3 | HIV//VIROLOGY//HIV 1 | 108954 |
| 10 | 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES//VIROLOGY//HIV 1 | 39664 |
| 21318 | 1 | ANTI R7V ANTIBODIES//C ADE//UNITE IMMUNORETROVIROL HUMAINE | 424 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | ANTI R7V ANTIBODIES | authKW | 288066 | 1% | 100% | 4 |
| 2 | C ADE | authKW | 216049 | 1% | 100% | 3 |
| 3 | UNITE IMMUNORETROVIROL HUMAINE | address | 162036 | 1% | 75% | 3 |
| 4 | BIOCHEM ENGN ARTIFICIAL HEART | address | 144033 | 0% | 100% | 2 |
| 5 | ENHANCING ANTIBODIES | authKW | 144033 | 0% | 100% | 2 |
| 6 | HOST DERIVED COMPONENT | authKW | 144033 | 0% | 100% | 2 |
| 7 | HUMAN IMMUNORETROVIROL | address | 135713 | 2% | 27% | 7 |
| 8 | INFECTION ENHANCEMENT | authKW | 108022 | 1% | 50% | 3 |
| 9 | T CELL INFECTION | authKW | 96021 | 0% | 67% | 2 |
| 10 | LUDWIG BOLTZMANN AIDS | address | 94741 | 2% | 13% | 10 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Virology | 10066 | 37% | 0% | 157 |
| 2 | Immunology | 5456 | 54% | 0% | 229 |
| 3 | Infectious Diseases | 1498 | 18% | 0% | 77 |
| 4 | Medicine, Research & Experimental | 117 | 7% | 0% | 31 |
| 5 | Microbiology | 78 | 7% | 0% | 30 |
| 6 | MEDICINE, MISCELLANEOUS | 44 | 0% | 0% | 1 |
| 7 | Allergy | 18 | 1% | 0% | 5 |
| 8 | Veterinary Sciences | 7 | 3% | 0% | 11 |
| 9 | Pathology | 4 | 2% | 0% | 7 |
| 10 | Biochemical Research Methods | 3 | 2% | 0% | 8 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | UNITE IMMUNORETROVIROL HUMAINE | 162036 | 1% | 75% | 3 |
| 2 | BIOCHEM ENGN ARTIFICIAL HEART | 144033 | 0% | 100% | 2 |
| 3 | HUMAN IMMUNORETROVIROL | 135713 | 2% | 27% | 7 |
| 4 | LUDWIG BOLTZMANN AIDS | 94741 | 2% | 13% | 10 |
| 5 | HUMAN IMMUNO RETROVIROL | 92589 | 1% | 43% | 3 |
| 6 | LEUKOCYTE IMMUNOCHEM | 88630 | 1% | 31% | 4 |
| 7 | BIOSTAT EPIDEMIOLSTAT DATA ANAL | 72016 | 0% | 100% | 1 |
| 8 | CLIN MOL IMMUNOL SECT | 72016 | 0% | 100% | 1 |
| 9 | DEVMED MOL BIOL UNIT | 72016 | 0% | 100% | 1 |
| 10 | DIRECTORS OFF BASIC SCI BASIC SCI | 72016 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 9802 | 6% | 1% | 27 |
| 2 | AIDS | 3324 | 5% | 0% | 20 |
| 3 | JOURNAL OF VIROLOGY | 2872 | 9% | 0% | 40 |
| 4 | VIROLOGY | 2207 | 6% | 0% | 24 |
| 5 | RETROVIROLOGY | 2122 | 1% | 0% | 6 |
| 6 | GENETIC ENGINEERING NEWS | 2050 | 1% | 1% | 5 |
| 7 | CHEMICAL & ENGINEERING NEWS | 1451 | 2% | 0% | 9 |
| 8 | CURRENT OPINION IN HIV AND AIDS | 1380 | 1% | 0% | 4 |
| 9 | JOURNAL OF IMMUNOLOGY | 1098 | 7% | 0% | 29 |
| 10 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1022 | 1% | 0% | 5 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ANTI R7V ANTIBODIES | 288066 | 1% | 100% | 4 | Search ANTI+R7V+ANTIBODIES | Search ANTI+R7V+ANTIBODIES |
| 2 | C ADE | 216049 | 1% | 100% | 3 | Search C+ADE | Search C+ADE |
| 3 | ENHANCING ANTIBODIES | 144033 | 0% | 100% | 2 | Search ENHANCING+ANTIBODIES | Search ENHANCING+ANTIBODIES |
| 4 | HOST DERIVED COMPONENT | 144033 | 0% | 100% | 2 | Search HOST+DERIVED+COMPONENT | Search HOST+DERIVED+COMPONENT |
| 5 | INFECTION ENHANCEMENT | 108022 | 1% | 50% | 3 | Search INFECTION+ENHANCEMENT | Search INFECTION+ENHANCEMENT |
| 6 | T CELL INFECTION | 96021 | 0% | 67% | 2 | Search T+CELL+INFECTION | Search T+CELL+INFECTION |
| 7 | AIDS ENHANCING ANTIBODIES | 72016 | 0% | 100% | 1 | Search AIDS+ENHANCING+ANTIBODIES | Search AIDS+ENHANCING+ANTIBODIES |
| 8 | ALLOIMMUNE SERA | 72016 | 0% | 100% | 1 | Search ALLOIMMUNE+SERA | Search ALLOIMMUNE+SERA |
| 9 | B CELL T CELL CO CULTURES | 72016 | 0% | 100% | 1 | Search B+CELL+T+CELL+CO+CULTURES | Search B+CELL+T+CELL+CO+CULTURES |
| 10 | CD4 INDEPENDENT HIV TRANSMISSION | 72016 | 0% | 100% | 1 | Search CD4+INDEPENDENT+HIV+TRANSMISSION | Search CD4+INDEPENDENT+HIV+TRANSMISSION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | HUBER, G , BANKI, Z , LENGAUER, S , STOIBER, H , (2011) EMERGING ROLE FOR COMPLEMENT IN HIV INFECTION.CURRENT OPINION IN HIV AND AIDS. VOL. 6. ISSUE 5. P. 419-426 | 44 | 44% | 9 |
| 2 | WILLEY, S , AASA-CHAPMAN, MMI , O'FARRELL, S , PELLEGRINO, P , WILLIAMS, I , WEISS, RA , NEIL, SJD , (2011) EXTENSIVE COMPLEMENT-DEPENDENT ENHANCEMENT OF HIV-1 BY AUTOLOGOUS NON-NEUTRALISING ANTIBODIES AT EARLY STAGES OF INFECTION.RETROVIROLOGY. VOL. 8. ISSUE . P. - | 43 | 41% | 18 |
| 3 | STOIBER, H , PRUENSTER, M , AMMANN, CG , DIERICH, MP , (2005) COMPLEMENT-OPSONIZED HIV: THE FREE RIDER ON ITS WAY TO INFECTION.MOLECULAR IMMUNOLOGY. VOL. 42. ISSUE 2. P. 153-160 | 37 | 54% | 38 |
| 4 | STOIBER, H , (2009) COMPLEMENT, FC RECEPTORS AND ANTIBODIES: A TROJAN HORSE IN HIV INFECTION?.CURRENT OPINION IN HIV AND AIDS. VOL. 4. ISSUE 5. P. 394-399 | 40 | 46% | 7 |
| 5 | XU, YY , ZHANG, CF , JIA, LL , WEN, CR , LIU, HH , WANG, Y , SUN, YS , HUANG, LY , ZHOU, YS , SONG, HB , (2009) A NOVEL APPROACH TO INHIBIT HIV-1 INFECTION AND ENHANCE LYSIS OF HIV BY A TARGETED ACTIVATOR OF COMPLEMENT.VIROLOGY JOURNAL. VOL. 6. ISSUE . P. - | 22 | 81% | 3 |
| 6 | STOIBER, H , BANKI, Z , WILFLINGSEDER, D , DIERICH, MP , (2008) COMPLEMENT-HIV INTERACTIONS DURING ALL STEPS OF VIRAL PATHOGENESIS.VACCINE. VOL. 26. ISSUE 24. P. 3046 -3054 | 38 | 45% | 29 |
| 7 | BANKI, Z , STOIBER, H , DIERICH, MP , (2005) HIV AND HUMAN COMPLEMENT: INEFFICIENT VIROLYSIS AND EFFECTIVE ADHERENCE.IMMUNOLOGY LETTERS. VOL. 97. ISSUE 2. P. 209 -214 | 31 | 57% | 24 |
| 8 | SPETH, C , STOIBER, H , DIERICH, MP , (2003) COMPLEMENT IN DIFFERENT STAGES OF HIV INFECTION AND PATHOGENESIS.INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. VOL. 130. ISSUE 4. P. 247 -257 | 42 | 45% | 9 |
| 9 | JIA, LL , XU, YY , ZHANG, CF , WANG, Y , CHONG, HH , QIU, SF , WANG, LG , ZHONG, YW , LIU, WJ , SUN, YS , ET AL (2010) A NOVEL TRIFUNCTIONAL IGG-LIKE BISPECIFIC ANTIBODY TO INHIBIT HIV-1 INFECTION AND ENHANCE LYSIS OF HIV BY TARGETING ACTIVATION OF COMPLEMENT.VIROLOGY JOURNAL. VOL. 7. ISSUE . P. - | 19 | 76% | 2 |
| 10 | STOIBER, H , SPETH, C , DIERICH, MP , (2003) ROLE OF COMPLEMENT IN THE CONTROL OF HIV DYNAMICS AND PATHOGENESIS.VACCINE. VOL. 21. ISSUE . P. S77 -S82 | 30 | 55% | 24 |
Classes with closest relation at Level 1 |